An anti-cancer medicine of “Taxotere”, has been produced at laboratory quantities, thanks to unsparing efforts of researchers and professors of Research Institute of Medicinal Raw Materials and Herbals of Shahid Beheshti University.
As reported by scientific service of ISNA, Docetaxel under the name of “Taxotere”, is one of the mostly consumed and the most expensive medicines of high frequency, used for control and treatment of such cancers as ovaries, prostates, breast, lungs and the ones.  
Presently, over 6 kilograms of the said medicine, equivalent of 50,000,000.- Dollars  is used in Iran. The said medicine is exclusively produced by a limited number of countries.
“Docetaxel is a semi-synthetic D amide, similar to Paklitaxel (a similar medicine), which is synthesized from a precursor material, derived from the leaves of  Taxus Bacca tree.
Presently, all production stages of the said medicine including synthesis and purification are done at laboratory quantity at Research Institute of Medicinal Raw Materials and Herbals of Shahid Beheshti University and it is possible to present the said medicine to pharmaceutical industry accordingly.

Chronic venous insufficiency is the main cause of Varicose Veins disease. While chronic venous insufficiency (CVI) is the most prevalent cause for leg pain and its inflation, this insufficiency occurs when venous valves lack the required performance and blood circulation in leg is impaired.
20% of adults suffer from this disease and on this basis the number of women is higher than men.
In this new treatment method, the disabled value is replaced with an efficient implant.
At the present time, this implant is not prepared to be used in the patients' bodies and it is in the trial phase.
In case this implant is put into practice, most vascular diseases can be treated through this method.
It should be mentioned that Erbaven Retard is one of the highly popular products of Yaghout Company. Besides causing positive effects in those patients suffering from varicose veins, this product has also been effective in the re-health of feet.

In a new achievement the American scientists have successfully manufactured a new manual system which injects a small ice bell under the skin and in this way it prevents from pain transmission in the patients suffering from arthritis.
The effect of this outpatient treatment which takes less then a few minutes is similar to local anesthetics; however, it has a longer effect.
Now the scientists have began a larger trial by using this method and have tested that on the patients suffering from knee arthritis.
When cartilages at the end of bones are destroyed as the result of abrasion, bones overlap and experience friction causing pain.
One out of each adult suffers from knee arthritis. Treatments for this pain encompass a range of steroid injections and calmatives to surgery and replacement of joints.
This system is called Cryo-Touch system and is a non-surgical approach which removes pharmaceutical need.
This icy treatment is a kind of Cryotherapy in which physicians use very cold temperatures to treat different diseases.
This treatment is used for different skin diseases including freezing of small skin cancers and benign tumors such as wart.
Cryotherapy is also used to treat prostate cancer in which physicians freeze cancer cells.
Researchers have recently used this method for the pain of joints especially in elbow, knee and shoulder.
This modern system that has been approved for use in UK is constituted of three stainless steel needles which are connected to a cylinder containing fluid nitrogen oxide.
These needles are designed to prevent from transmission of this very cold material into tissues which may cause serious injuries in case of contact.
Instead, when the fluid exits from the needle, it will change into gas due to very high pressure. This causes the needle to become very cold and an icy ball is produced on its top. In this system, three needles are used to increase the icy ball volume.
These needles are plunged within a few millimeters under the skin. Then, the system starts and a small icy ball is formed under the skin.
This icy ball damages to the blood vessels that transmit blood to the peripheral nerves around the joint. These nerves cannot send pain signs without any blood source.
Each treatment takes about 5 minutes. The physician lets the icy ball to become warm and then pulls out the needles.
A former human research conducted by the University of Washington with a similar technology showed that this treatment was effective for some patients and its effect remained for eight months.
The pain returns with the growth of new blood vessels and reactivation of nerves. In such case, another injection period may be effective.

Benefiting from kind assistance of a group of top specialists of the country in organic medicines, Sepid Teb Nia Pharmaceutical Research and Development Company has celebrated honorable commencement of its activity in Sept of this year. In the said eve, Dr Seyed Jafar Mir Fakhraee, Secretary of Syndicates for Manufacturers of Herbal Medicines stated that accomplishment of various projects in the country in the areas of pharmaceutical engineering, molecular biology and formulation promises ever-increasing promotion of scientific level and realization of divine goals of health in the society and the most significant reliance of practitioners in the said area is to obtain the most important and effective achievements in the said industry. Moreover, Ms Dr Pour Shaghaghi, Managing Director of Sepid Teb Nia Company stated on scientific characteristics of the said center and further added: Thanks to valuable knowledge and scientific learning of its colleagues, Sepid Teb Nia Company has the capability to exchange technologies for producing herbal medicines and supplements at global quality standard levels through active and well-known producers all over the world (especially European producers) to our beloved homeland, Iran, the said Company may act upon development of new formulations, innovation in taking the best advantages of fresh compounds and materials, and eventually producing distinguished products in the Middle East.
Moreover, Dr Seyed Hossein Etemadi, the founder of Yaghout Rooyan Corporation, stated that he was grateful with accomplishment of the aforesaid project. He further added that being pioneer in presenting essential approaches with respect to public health promotion shall be an honor for this Company because we all do believe that the most significant concern of each Iranian individual is to serve his beloved homeland and to Iranians. He pointed out that materialization of research projects in the said field, modification of pharmaceutical problems of people of different classes, optimization of safety-pharmaceutical standards in the nation and reengineering of production procedures in the said area all designate growingly jump of the said industry. In conclusion, he stated his hopefulness for registration of new medicines, manufactured by the said Company in near future with scientific circles and distribution of the same in global production markets accordingly. He also pleaded with Almighty God for ever-increasing success of health practitioners across the nation.

Feedbacks:{jcomments on}